Unknown

Dataset Information

0

Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.


ABSTRACT: Dendritic cells (DCs) are potent professional antigen presenting cells (APC) that activate nai?ve T cells. Interaction of ICAM-1 and LFA-1 molecules on each cell is required for T cell conjugation to DCs, which leads to nai?ve CD4+ T cell activation and proliferation. Nanoparticles capable of blocking LFA-1/ICAM-1 interaction were studied as inhibitors of T cell conjugation to DCs. Primary DCs were primed with ovalbumin, then treated with a peptide that binds ICAM-1 (LABL), a peptide that binds LFA-1 (cIBR), or the same peptides covalently linked to the surface of poly(dl-lactic-co-glycolic acid) nanoparticles (NPs). LABL-NPs and cIBR-NPs rapidly bound to DCs and inhibited T cell conjugation to DCs to a greater extent than the free peptides, unconjugated nanoparticles (NPs), anti-ICAM-1 antibodies, and anti-LFA-1 antibodies. In addition, DCs treated with NPs or with cIBR-NPs stimulated the proliferation of T cells, but DCs treated with LABL-NPs did not stimulate T cell proliferation. Nanoparticles targeting ICAM-1 or LFA-1 also altered cytokine production by DC cocultured with T cells when compared to free ligands, suggesting that these NPs may offer a unique tool for shaping T cell response.

SUBMITTER: Chittasupho C 

PROVIDER: S-EPMC4207654 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.

Chittasupho Chuda C   Shannon Laura L   Siahaan Teruna J TJ   Vines Charlotte M CM   Berkland Cory C  

ACS nano 20110304 3


Dendritic cells (DCs) are potent professional antigen presenting cells (APC) that activate naïve T cells. Interaction of ICAM-1 and LFA-1 molecules on each cell is required for T cell conjugation to DCs, which leads to naïve CD4+ T cell activation and proliferation. Nanoparticles capable of blocking LFA-1/ICAM-1 interaction were studied as inhibitors of T cell conjugation to DCs. Primary DCs were primed with ovalbumin, then treated with a peptide that binds ICAM-1 (LABL), a peptide that binds LF  ...[more]

Similar Datasets

| S-EPMC5295143 | biostudies-literature
| S-EPMC7766908 | biostudies-literature
| S-EPMC2641028 | biostudies-literature
| S-EPMC4675334 | biostudies-literature
| S-EPMC3421720 | biostudies-literature
| S-EPMC1765441 | biostudies-literature
| S-EPMC8368787 | biostudies-literature
| S-EPMC6787174 | biostudies-literature
| S-EPMC8703776 | biostudies-literature
| S-EPMC8336483 | biostudies-literature